Worldwide Transcatheter Pulmonary Valve (TPV) Therapy Market Insights: Industry Size, Growth Analysis and Forecast
Report ID : 1372377 | Published : February 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Transcatheter Pulmonary Valve (TPV) Therapy Market is categorized based on Product Type (Self-expanding TPV, Balloon-expandable TPV) and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) and Application (Valvular Heart Disease, Congenital Heart Defects) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
In 2023, the Transcatheter Pulmonary Valve (TPV) Therapy Market size was $300 million and is projected to grow to $1.2 billion by 2033, registering a CAGR of 15.2% from 2024 to 2033. This report includes multiple segments and provides an analysis of key trends and factors playing a substantial role in the market.
Because of the advancement in minimally invasive measures undertaken for the management of cardiac procedures, the Transcatheter innovative Pulmonary Valve Therapy Market is poised for growth. Congenital heart defect patients particularly with pulmonary stenosis and regurgitation disease can benefit with this innovative valve therapy. The use of a catheter allows TPV therapy to be much safer, less invasive, and more effective when compared to traditional surgical interventions. Traditional surgeries have long recovery periods which are negligent with TPV Therapy skill set.
Therapies such as these TPV ones that are more centered towards the needs of patients will continue to be in high demand. Improving technology, population growth, and the increasing awareness are all factors escalating the demand for this service. In addition, continuous development is working towards the creation of new generations of TPV devices that are more effective and versatile in their applications. This industry holds unique promise and opportunities for the development of new pulmonary valve disorder treatment options for the physicians, businesses and industry investors.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Medtronic, Edwards Lifesciences, Boston Scientific, Abbott Laboratories, JenaValve Technology, Tendyne Holdings, Sahajanand Medical Technologies, LivaNova, Cardiovalve, Acurate, Corvia Medical |
| SEGMENTS COVERED |
By Product Type - Self-expanding TPV, Balloon-expandable TPV
By End User - Hospitals, Cardiac Centers, Ambulatory Surgical Centers
By Application - Valvular Heart Disease, Congenital Heart Defects
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Transcatheter Pulmonary Valve (TPV) Therapy Market Dynamics
The Transcatheter Pulmonary Valve (TPV) Therapy Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Transcatheter Pulmonary Valve (TPV) Therapy Market Segmentations
Market Breakup by Product Type
- Overview
- Self-expanding TPV
- Balloon-expandable TPV
Market Breakup by End User
- Overview
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
Market Breakup by Application
- Overview
- Valvular Heart Disease
- Congenital Heart Defects
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Transcatheter Pulmonary Valve (TPV) Therapy Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Medtronic
- Edwards Lifesciences
- Boston Scientific
- Abbott Laboratories
- JenaValve Technology
- Tendyne Holdings
- Sahajanand Medical Technologies
- LivaNova
- Cardiovalve
- Acurate
- Corvia Medical
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved